Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
100627852 | 10062785 | 2 | F | 20140206 | 20140401 | 20150331 | PER | PHEH2013US024744 | NOVARTIS | 73.00 | YR | F | N | 0.00000 | 20150204 | N | CN | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
100627852 | 10062785 | 1 | PS | EXELON | RIVASTIGMINE TARTRATE | 1 | D | D | 20823 | 1.5 | MG | BID | |||||||
100627852 | 10062785 | 3 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
100627852 | 10062785 | 5 | C | ASPIRIN (ACETYLSALICYLIC ACID) | ASPIRIN | 1 | 0 |
Indications of drugs used
no results found |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
100627852 | 10062785 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
100627852 | 10062785 | Abdominal pain upper | |
100627852 | 10062785 | Dizziness | |
100627852 | 10062785 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
Event ID | CASEID | RPSR COD |
---|---|---|
100627852 | 10062785 | CSM |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
100627852 | 10062785 | 1 | 20131119 | 0 |